GI Oncology
In Focus
Diagnosis and management of gastric intestinal metaplasia in the United States
From the Journals
Clopidogrel matches aspirin for reducing risk of colorectal cancer
The study authors hypothesize that the chemoprotective effect of low-dose aspirin is mediated mostly through the permanent inactivation of...
From the Journals
Colorectal cancer diagnoses still moving up in younger adults, with no sign of plateau
Incidence increased from 10% to 12% over a decade in the analysis of a large U.S. cancer registry.
From the Journals
Test could inform care of patients with pancreatic cysts
The test, CompCyst, correctly identified 91% of patients who required surgery, 49% of those who required monitoring, and 60% of patients who...
Conference Coverage
Microbiome – Impact on health and disease
The gut microbiota influences colon cancer, liver disease, and the production of bioactive compounds.
Conference Coverage
The changing epidemiology of hepatocellular carcinoma
Risk factors for cirrhosis and HCC in contemporary clinical practice have shifted from active viral hepatitis to resolved hepatitis C infection or...
From the Journals
Endoscopic treatment effective in T1b esophageal cancer
A systematic review suggests endoscopic treatment is appropriate for T1b esophageal cancers with a low risk of metastasis.
From the Journals
Genomic study reveals five subtypes of colorectal cancer
Drug treatments may be developed for cancers that genetic analyses have identified as having different methylation subtypes.
From the Journals
Barrett’s esophagus endoscopies are undersampled
A significant number of endoscopies in patients with Barrett’s esophagus are not done according to the Seattle biopsy protocol.
Video
Study finds differences for HCC in women
SAN DIEGO – Women were significantly more likely to present without cirrhosis and with nonalcoholic fatty liver disease than were men.